The Evidence Based Rheumatology Podcast

22 Dec 2025 11:07

E130: Telitacicept for SLE

Surprisingly (unbelievably?) impressive RCT evaluating the Blys/APRIL inhibitor "telitacicept" for patients with SLE (mixed SLE and SLE-LN). Very curious to see where the FDA goes with this one.

Paper: https://www.nejm.org/doi/full/10.1056/NEJMoa2414719

Отзывы

Podcastly – the best platform for podcasters and podcast lovers. More than 10 millions of audio content that available on Android/iOS/Web/Desktop and Telegram.

Social networks

Select language

🇺🇸